Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

NCT06246799 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

256

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes (Adult Onset)

Interventions

DRUG: Tirzepatide
DRUG: Pioglitazone
DRUG: Sitagliptin
DRUG: Metformin HCI XR

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)